Bern-Thomas Nyang'wa is a Malawian-British Project Manager and Chief Investigator for the TB-PRACTECAL clinical trial.

Sponsored by MSF, the study is evaluating new approaches to combat multidrug-resistant tuberculosis (TB) – a strain of the illness that does not respond to first-line antibiotics and can require an arduous two-year treatment.

Since February 2021, Bern has been working as a medical director for MSF based at our Amsterdam headquarters.